相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Developments in the treatment of visceral leishmaniasis
Margriet Leontine den Boer et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Paromomycin in the treatment of leishmaniasis
Shyam Sundar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses
Antara Banerjee et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-10 and TGF-β control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice
Charles F. Anderson et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-10- and TGF-β-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis:: The significance of amphotericin B in the control of Leishmania donovani infection in India
Samiran Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+ CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis
Susanne Nylen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Interleukin-10 and the pathogenesis of human visceral leishmaniasis
Susanne Nylen et al.
TRENDS IN IMMUNOLOGY (2007)
Liposomal amphotericin B for the treatment of visceral leishmaniasis
Caryn Bern et al.
CLINICAL INFECTIOUS DISEASES (2006)
Elevated levels of interferon-γ, interleukin-10, interleukin-6 during active disease in Indian kala azar
Nasim Akhtar Ansari et al.
CLINICAL IMMUNOLOGY (2006)
New formulations and derivatives of amphotericin B for treatment of leishmaniasis
J Golenser et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2006)
Balance of IL-10 and interferon-γ plasma levels in human visceral leishmaniasis:: Implications in the pathogenesis -: art. no. 113
A Caldas et al.
BMC INFECTIOUS DISEASES (2005)
Treatment of visceral leishmaniasis
S Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Treatment options for visceral leish maniasis: a systematic review of clinical studies done in India, 1980-2004
PL Olliaro et al.
LANCET INFECTIOUS DISEASES (2005)
Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis
HW Murray et al.
INFECTION AND IMMUNITY (2005)
Drugs against leishmaniasis: a synergy of technology and partnerships
AJ Davis et al.
TRENDS IN PARASITOLOGY (2004)
Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis
HW Murray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Transforming growth factor-beta in T-cell biology
L Gorelik et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
S Sundar et al.
BRITISH MEDICAL JOURNAL (2001)
Reduction of NO synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers
M Larabi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
